High-Output Heart Failure Caused by Thyrotoxicosis and Beriberi.

High-output heart failure is not seen as commonly as low-output heart failure and some of the typical guideline recommendations may not benefit patients with high-output failure. High-output failure is caused by several diseases, including thyrotoxicosis and beriberi, highlighted in this article. Thyrotoxicosis, caused by excessive thyroid hormone production, has profound hemodynamic effects.

Heart Failure and Atrial Fibrillation.

Atrial fibrillation is commonly experienced by patients with heart failure, and as the heart failure progresses and worsens, the more likely the patient is to develop atrial fibrillation. Several factors play into this, including common risk factors, such as advanced age, hypertension, and ischemic or valvular heart disease. Treatment is aimed at anticoagulation, to prevent thromboembolic stroke, and rate control to prevent further hemodynamic compromise.

Use of the Impella 2.5 in high-risk percutaneous coronary intervention.

The Impella 2.5 is a percutaneously placed partial circulatory assist device that is increasingly being used in high-risk coronary interventional procedures to provide hemodynamic support. The Impella 2.

Don't ignore that call for posters!

Participating in a conference poster session is an effective way to share information about clinical practice. This column offers some practical tips to help with the process of developing a visually appealing and informative poster.